Addus HomeCare (NASDAQ:ADUS) Coverage Initiated at JMP Securities

Analysts at JMP Securities assumed coverage on shares of Addus HomeCare (NASDAQ:ADUS) in a report released on Monday, Marketbeat reports. The firm set an “outperform” rating and a $150.00 price target on the stock. JMP Securities’ price target would indicate a potential upside of 14.74% from the company’s previous close.

A number of other research analysts have also commented on the stock. Stephens raised their price objective on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research note on Wednesday, November 6th. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. StockNews.com upgraded shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Oppenheimer upped their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, KeyCorp started coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $133.67.

Addus HomeCare Stock Performance

NASDAQ:ADUS opened at $130.73 on Monday. The company has a market capitalization of $2.37 billion, a price-to-earnings ratio of 29.92, a price-to-earnings-growth ratio of 2.11 and a beta of 1.01. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12. The stock has a 50-day simple moving average of $125.76 and a 200 day simple moving average of $124.69.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $1.03 earnings per share. On average, equities research analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Transactions at Addus HomeCare

In other Addus HomeCare news, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction that occurred on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of the firm’s stock in a transaction that occurred on Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Wasatch Advisors LP grew its position in shares of Addus HomeCare by 11.8% in the 3rd quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock valued at $138,782,000 after acquiring an additional 110,010 shares during the period. Point72 Asset Management L.P. grew its position in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after acquiring an additional 315,602 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock valued at $82,930,000 after acquiring an additional 5,421 shares during the period. State Street Corp boosted its holdings in shares of Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after buying an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. boosted its holdings in shares of Addus HomeCare by 17.5% during the 3rd quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock worth $67,293,000 after buying an additional 75,409 shares during the period. 95.35% of the stock is currently owned by institutional investors and hedge funds.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.